About Lee Schoentrup

This author has not yet filled in any details.
So far Lee Schoentrup has created 106 blog entries.

Biking for the Health of It

May 11th, 2016|Blog|

Bike Everywhere Month—the new, more ambitious Bike to Work Month—is now under way with IDRI riding along. We’ve kicked off May 2016 with a bike safety seminar and discussion of safe routes, along with a breakfast rally to get us [...]

Bike Anywhere Day 2016

May 9th, 2016|Events|

May 20, 2016 Event Details: Bike Anywhere Day 2015 May 20, 2016 6-9 a.m. IDRI 1616 Eastlake Avenue East Seattle, WA 98102 IDRI (Infectious Disease Research Institute) is teaming with Grand Central Bakery and Caliber Home Loans to host a [...]

Seattle Researcher Thinks Key to Zika Vaccine Could Be in West Nile Virus Vaccine

May 2nd, 2016|News|

IDRI’s 3rd Annual Gift Guide for Geeks

December 15th, 2015|Blog|

The pressure is on. Shopping days are numbered. Expectations are high. What do you get for your favorite geek on your holiday shopping list??? We asked that question of IDRI employees, who shared their recommendations for their best gift ideas for geeks. What happens when the power goes out and your cell phone dies? Never fear, says Chris Antony. Just make sure you have this hand crank emergency charger on hand. A great stocking stuffer! For the geek who likes to cook, Rob Lin suggests these two great cookbooks that combine science and cooking: The Food Lab: Better Home Cooking Through Science and Cooking for Geeks: Real Science, Great Cooks and Good Food. For the geek who likes a nice glass of wine every now and again, Elyse Beebe suggests these beaker wine glasses from the I Love Science Store. From Alyssa Manning: “I suggest My Inventions: The Autobiography of Nikola Tesla. I got it for my geeky Dad last year!” If you have loved ones who want to use technology to monitor their health, Aarthy Vallur recommends the AliveCor Mobile ECG. “It’s a great gift for parents or retirees. I got one for both my Dad and my in-laws and they love it!” […]

Now is the Time: HIV Cure

December 1st, 2015|Blog, HIV/AIDS|

A couple years ago, the Annenberg Foundation Trust at Sunnylands convened dozens of leaders from science, government, philanthropy and industry at a meeting called the “Summit on Public-Private Partnerships for Research Toward a Cure.” IDRI was honored to be represented at this meeting as we discussed ways to bring HIV to an end. From this meeting the following strong and important consensus statement was agreed upon:  “More than 30 years into the global HIV/AIDS pandemic, scientific and clinical research has taken us to the point where a cure for HIV/AIDS is possible. Driven by the evidence supporting such possibility, The Annenberg Retreat at Sunnylands recently brought together key stakeholders from academia, government, foundations, and industry to discuss what actions could be taken to accelerate efforts towards the goal of a cure for HIV infection. The group concluded that now is the time to work collectively and aggressively to reach this goal with the ultimate objective of making a cure available to every person in need, wherever they happen to live in the world. Although effective antiviral therapies exist that can control HIV infection, curing HIV/AIDS — eradicating the virus from infected individuals or eliminating the need for lifelong antiviral therapy — will require an extraordinary, collaborative global effort, backed by strong and sustained political and industrial leadership. We believe that developing a cure for HIV is one of the most important biomedical challenges of the 21st century. It is clear that the task is too large and too complex for any one laboratory, company, or country to undertake in isolation. […]

Antibiotic Resistance: Are You Contributing to the Problem?

November 16th, 2015|Blog, Drugs, Tuberculosis|

How many times have you been prescribed antibiotics and didn’t finish the course of treatment? Maybe you were feeling better or  thought “I could save the rest of these in case I get sick again.” If so, you are a contributor to the rise of antibiotic resistance — and you might not realize it. This week, Nov. 16-22, has been designated by the World Health Organization as “World Antibiotic Awareness Week,” designed to increase awareness of global antibiotic resistance and encourage best practices, such as completing a full course of antibiotics when prescribed and not sharing antibiotics prescribed for you with others. “The rise of antibiotic resistance is a global crisis. It’s one of the greatest threats to health today. This makes a broad range of common infections much more difficult to treat, replacement treatment are more costly, more toxic, and require much longer periods of time for treatment,” WHO director-general Dr. Margaret Chan said in a news conference. […]

The Emerald City: Filled with Generosity

October 20th, 2015|Blog, HIV/AIDS|

NOTE: Susan Galea is Director, Global Clinical Safety and Pharmacovigilance, for Merck; she is working for three months at IDRI as part of the Merck Fellowship for Global Health program. Galea and another Merck fellow, Todd Kennedy, are working on the HIV Cure Initiative, for which IDRI serves as the fiscal sponsor. Maybe I have been drinking the philanthropic water of this city, but I would be remiss not to mention the generosity that I have seen from day one of my Fellowship. The substantial investment that Merck has provided for these Fellowships can’t be overlooked. Simply put, through the Fellows that they provide, Merck is attempting to fortify nonprofit organizations with technical and human support. Specifically, here in Seattle, they have paired Todd Kennedy and me with the Infectious Disease Research Institute (IDRI) and our sponsor Erik Iverson. This organization is genuinely advancing global health. Many of the world’s most devastating diseases are getting attention here as they focus on new diagnostics, adjuvants, drugs and vaccines for diseases such as leprosy, leishmaniasis and tuberculosis. So why is IDRI the fiscal sponsor for HIV Cure Initiative?  They believe in the importance of this collaboration and give generously of their time with the belief that they share with relevant scientists:  HIV can be functionally cured or at least put into a remission state. […]

Nobel Prize Calls Attention to Diseases of Poverty

October 9th, 2015|Blog, Malaria|

A lot of excitement is generated during the week the Nobel Prizes are awarded. This particular Nobel week was extra special for any microbiologist or drug hunter as the Nobel Prize in Physiology or Medicine for 2015 was awarded to three scientists involved in discovering important and novel therapies for parasitic diseases – malaria and roundworms. Youyou Tu was awarded for the discovery of artemisinin, a product derived from a plant (sweet wormwood) used in traditional Chinese medicine, that had excellent activity against the malaria parasite. She was instrumental in discovering the active ingredient in the plant, which can be a difficult and long process, as well figuring out its chemical structure. This led to artemisinin becoming part of the treatment for malaria and a great deal of human suffering being avoided. Although artemisinin resistance has appeared, it still forms part of combination therapy used to treat malaria, and has formed part of new treatments that reduced death rates almost by half. […]

IDRI and Wellcome Trust Team for Tuberculosis Vaccine Trial in South Africa

September 17th, 2015|Press Releases|

Seattle, WA | September 17, 2015 FOR IMMEDIATE RELEASE: SEATTLE, September 17, 2015: Today, the Infectious Disease Research Institute (IDRI) and Wellcome Trust announce the start of a Phase 2a trial in South Africa of IDRI’s tuberculosis (TB) vaccine [...]

Going Global from Seattle? Collaboration and Caffeine

September 8th, 2015|HIV/AIDS|

NOTE: Todd Kennedy is a National Account Executive for Merck, who is working for three months at IDRI as part of the Merck Fellowship for Global Health program. Kennedy and another Merck fellow, Susan Galea, are working on the HIV Cure Initiative, for which IDRI serves as the fiscal sponsor. This is the Richard T. Clark Fellowship for Global Health, right? Wait, then what is a California guy doing in Seattle, Washington? In 12 short weeks can my fellow colleague Susan Galea and I make a significant global impact from the land of salmon, apples and grunge? These are the questions I was considering, before work on day 1 as I was sipping espresso from the original Starbucks at Pike Place Market. By 8:30 a.m., the potential and promise of our assignment came into focus. From the window of our sponsor’s conference room, you can literally see the offices of pivotal public and private stakeholders including leading NGOs (Bill and Melinda Gates Foundation, Paul G. Allen Family Foundation), academia, pharma and biotech. It seems clear that the key to addressing global health challenges is collaboration among trusted partners, many of whom are located right here in the Pacific Northwest. Working with the Infectious Disease Research Institute (IDRI), Susan and I have been asked to: “support development of an ‘investment case’ that will set forth a global health and economic rationale to catalyze multi-sector engagement in a strategic, collaborative effort to identify, develop, and distribute a cure for HIV that will be accessible in both high- and low-resource geographic settings.” […]

Load More